Analyst Ratings for Rexnord (RXN)
RXN Rating Summary
RXN Price Target Summary
- Highest: $27.00 (Baird)
- Lowest: $18.00 (BofA/Merrill Lynch)
- Average: $22.00
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$22.00 (+15.5%)
Avg. $ Target:
$22.00 (+15.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/13/2013 | Barclays | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
21.00 | 19.04 | -9.33% | Details |
| 2/7/2013 | BMO Capital | Downgrade | Market Perform (Outperform) |
21.00 (21.00) |
20.33 | 19.04 | -6.35% | Details |
| 1/7/2013 | Deutsche Bank | Downgrade | Sell (Hold) |
19.00 (21.00) |
21.18 | 19.04 | -10.1% | Details |
| 12/14/2012 | Janney Montgomery Scott | New Coverage | Neutral (N/A) |
22.00 (N/A) |
20.94 | 19.04 | -9.07% | Details |
| 8/9/2012 | BofA/Merrill Lynch | New Coverage | Neutral (N/A) |
18.00 (N/A) |
15.58 | 19.04 | 22.21% | Details |
| 5/11/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
23.00 (N/A) |
21.74 | 19.04 | -12.42% | Details |
| 5/8/2012 | Baird | New Coverage | Outperform (N/A) |
27.00 (N/A) |
22.02 | 19.04 | -13.53% | Details |
| 5/8/2012 | Goldman Sachs | New Coverage | Neutral (N/A) |
24.00 (N/A) |
22.02 | 19.04 | -13.53% | Details |
